Posted by Two Blokes
Denifanstat met all primary and secondary endpoints versus placebo Denifanstat was well tolerated Oral FASN in
Source: Two Blokes Trading
Posted by Two Blokes
I bought the (short-lived) dip on June 2. In my view, the terms of the $1B private placement are highly favora
Source: Two Blokes Trading
Posted by Two Blokes
First Solar's stock (NASDAQ: FSLR) has experienced a significant decline — down almost 50% from its peak of ar
Source: Two Blokes Trading
Posted by Two Blokes
The grocer sold a 7% shareholding in Carmila for $194.5 million as part of a strategic review of its portfolio
Source: Two Blokes Trading
Posted by Two Blokes
For more than three decades, investors have consistently had a game-changing innovation or next-big-thing tren
Source: Two Blokes Trading
Posted by Two Blokes
Newsmax (NMAX -5.06%), a media company with conservative leanings, was founded in 1998 and has grown rapidly o
Source: Two Blokes Trading
Posted by Two Blokes
It might seem tough for a stock to deliver a five-bagger gain in just five years. But over the past five years
Source: Two Blokes Trading
Posted by Two Blokes
Shares of Zscaler (ZS 0.74%) have soared by an eye-popping 51% in 2025 so far, bucking the pessimism in the br
Source: Two Blokes Trading
Posted by Two Blokes
A few years ago, Moderna (MRNA 2.77%) stock represented the ticket to an investing win. The company brought it
Source: Two Blokes Trading
Posted by Two Blokes
So far, Apple's (AAPL 0.83%) efforts in artificial intelligence (AI) have underwhelmed investors, and it's fai
Source: Two Blokes Trading
Posted by Two Blokes
Shares of Dell Technologies (DELL 3.53%) have underperformed the broader market in the past year, losing 20% o
Source: Two Blokes Trading
Posted by Two Blokes
StealthGas is a deeply discounted LPG shipping stock with 27 of 28 owned vessels debt-free, ensuring strong ca
Source: Two Blokes Trading